High-performance liquid chromatographic determination of proglumide in plasma. 1982

T Marunaka, and Y Minami, and Y Umeno, and E Matsushima

A rapid and sensitive method for determining the anticholinergic agent, proglumide, in plasma by high-performance liquid chromatography is described. Samples were acidified with hydrochloric acid and extracted with chloroform. The dried extract was resolved in chloroform and chromatographed on an adsorption chromatographic column using a mobile phase of chloroform-methanol (24:1) on a high-performance liquid chromatograph equipped with a UV absorbance detector (240 nm). The detection limit for proglumide was 0.05 microgram/ml.

UI MeSH Term Description Entries
D008297 Male Males
D011377 Proglumide A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Xylamide,Milid,Xilamide
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
February 1978, Clinical chemistry,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
November 1979, Journal of pharmaceutical sciences,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
January 1982, Journal of pharmaceutical sciences,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
April 1981, Journal of pharmaceutical sciences,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
July 1990, Journal of chromatography,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
June 1993, Journal of clinical pharmacy and therapeutics,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
April 1992, Journal of clinical pharmacy and therapeutics,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
May 1985, Journal of chromatography,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
November 1987, Journal of chromatography,
T Marunaka, and Y Minami, and Y Umeno, and E Matsushima
March 1990, Therapeutic drug monitoring,
Copied contents to your clipboard!